Union européenne - islandais - EMA (European Medicines Agency)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - blóðþurrðandi lyf - bráðri kransæðastíflu syndromemyocardial hjartaáfall.

Union européenne - islandais - EMA (European Medicines Agency)

sanofi winthrop industrie - insúlín lispró - sykursýki - lyf notuð við sykursýki - fyrir meðferð fullorðna og börn með sykursýki sem þurfa insúlín til að viðhalda eðlilegt glúkósa homeostasis. insúlín lispró sanofi er einnig ætlað til upphafs stöðugleika sykursýki.

Union européenne - islandais - EMA (European Medicines Agency)

sanofi winthrop industrie - insúlín aspart - sykursýki - lyf notuð við sykursýki - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - zolpidemum tartrat - filmuhúðuð tafla - 10 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - zopiclonum inn - filmuhúðuð tafla - 7,5 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - amisulpridum inn - tafla - 200 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - amisulpridum inn - tafla - 50 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - amiodaronum hýdróklóríð - tafla - 200 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - amiodaronum hýdróklóríð - tafla - 100 mg

Islande - islandais - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - hydroxychloroquinum súlfat - filmuhúðuð tafla - 200 mg